These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fetal immune responses to Plasmodium falciparum antigens in a malaria-endemic region of Cameroon. Metenou S; Suguitan AL; Long C; Leke RG; Taylor DW J Immunol; 2007 Mar; 178(5):2770-7. PubMed ID: 17312120 [TBL] [Abstract][Full Text] [Related]
23. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana. Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262 [TBL] [Abstract][Full Text] [Related]
24. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701 [TBL] [Abstract][Full Text] [Related]
25. Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin. Rasti N; Namusoke F; Chêne A; Chen Q; Staalsoe T; Klinkert MQ; Mirembe F; Kironde F; Wahlgren M Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13795-800. PubMed ID: 16945914 [TBL] [Abstract][Full Text] [Related]
26. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission. Riley EM; Morris-Jones S; Blackman MJ; Greenwood BM; Holder AA Parasite Immunol; 1993 Sep; 15(9):513-24. PubMed ID: 7877849 [TBL] [Abstract][Full Text] [Related]
27. Acquisition and decay of IgM and IgG responses to merozoite antigens after Plasmodium falciparum malaria in Ghanaian children. Walker MR; Knudsen AS; Partey FD; Bassi MR; Frank AM; Castberg FC; Sarbah EW; Ofori MF; Hviid L; Barfod L PLoS One; 2020; 15(12):e0243943. PubMed ID: 33332459 [TBL] [Abstract][Full Text] [Related]
28. The use of crude Plasmodium falciparum antigens for comparison of antibody responses in patients with mild malaria vs. cerebral malaria. Mbengue B; Niang B; Diatta B; Tall A; Garraud O; Perraut R; Dieye A Iran J Immunol; 2010 Sep; 7(3):150-61. PubMed ID: 20876986 [TBL] [Abstract][Full Text] [Related]
29. Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic. Høgh B; Marbiah NT; Burghaus PA; Andersen PK Infect Immun; 1995 Oct; 63(10):4034-8. PubMed ID: 7558316 [TBL] [Abstract][Full Text] [Related]
30. Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR. Morgan WD; Lock MJ; Frenkiel TA; Grainger M; Holder AA Mol Biochem Parasitol; 2004 Nov; 138(1):29-36. PubMed ID: 15500913 [TBL] [Abstract][Full Text] [Related]
31. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270 [TBL] [Abstract][Full Text] [Related]
32. Naturally acquired antibody responses to the components of the Plasmodium falciparum merozoite surface protein 1 complex. Wang L; Crouch L; Richie TL; Nhan DH; Coppel RL Parasite Immunol; 2003; 25(8-9):403-12. PubMed ID: 14651587 [TBL] [Abstract][Full Text] [Related]
33. Human IgG responses against the N-terminal region of the Merozoite Surface Protein 1 of Plasmodium vivax. del Portillo HA; Levitus G; Camargo LM; Ferreira MU; Mertens F Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():77-84. PubMed ID: 1343729 [TBL] [Abstract][Full Text] [Related]
34. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil. Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960 [TBL] [Abstract][Full Text] [Related]
35. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria. Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203 [TBL] [Abstract][Full Text] [Related]
36. Synthetic Antigens Derived from Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339 [TBL] [Abstract][Full Text] [Related]
37. Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas. Adu B; Cherif MK; Bosomprah S; Diarra A; Arthur FK; Dickson EK; Corradin G; Cavanagh DR; Theisen M; Sirima SB; Nebie I; Dodoo D Malar J; 2016 Feb; 15():123. PubMed ID: 26921176 [TBL] [Abstract][Full Text] [Related]
38. Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype. Al-Yaman F; Genton B; Reeder JC; Mokela D; Anders RF; Alpers MP Am J Trop Med Hyg; 1997 Apr; 56(4):430-5. PubMed ID: 9158053 [TBL] [Abstract][Full Text] [Related]